Integrated Delivery Networks in the US

  • ID: 4421395
  • Report
  • Region: United States
  • 71 pages
  • Datamonitor Healthcare
1 of 3
Overview

Integrated delivery networks (IDNs) are a growing approach to streamlined healthcare in the US, providing support from the cradle to the care home. The formation of IDNs is driven by increases in healthcare spending and the desire to reduce costs while maintaining patient outcomes and quality of care. This analysis discusses the market and healthcare forces behind the creation of the IDN sector, analyzes the role of IDNs in providing care for people at different key stages of their life, and assesses the ways that IDNs tackle controlling drug costs.

Pharmaceutical companies need to adapt their sales and marketing approaches to follow the changes that have come with the development of IDNs. IDNs have different decision-making processes, the size to leverage price discussions, and access to real-world data in order to understand a drug's true value. As a result, pharmaceutical companies need to understand what IDNs want, build better value into their products, and up skill their sales teams to be able to communicate to these new and growing organizations.
Note: Product cover images may vary from those shown
2 of 3
1 EXECUTIVE SUMMARY
  • Key findings
2 CHALLENGES IN HEALTHCARE
  • Changing population demographics
  • Increasing prevalence of chronic disease
  • Medical innovation is also driving healthcare spending
  • Pressure on funding
  • Bibliography
3 PAYMENT PRESSURES: IDNS AS A SOLUTION
  • Focus on value is driving creation of new healthcare entities
  • New healthcare entities are a result of the shift towards consolidation
  • Integrated delivery networks: A definition
  • The benefits of IDNs
  • Streamlining the healthcare pathway
  • Measuring the performance of IDNs
  • Other integrated healthcare structures
  • Bibliography
4 THE GROWTH OF IDNS
  • The number of IDNs is growing
  • The top IDNs: facts and figures
  • Examples of IDNs
  • Bibliography
5 IDNS’ FOCUS
  • Preventing chronic disease
  • Caring for diseases of older age
  • Managing the costs of high-intensity care
  • Supporting patients through transitions in care
  • Finding the best care for patients: specialist and community cancer care
  • Bibliography
6 IDNS AND MEDICINES MANAGEMENT
  • The role of formularies in IDN cost cutting
  • Working with specialty pharmaceuticals increasingly important for IDNs’ cost containment
  • IDNs' effective medicines management can improve adherence and cost
  • Bibliography
7 IDNS ARE MAKING AN IMPACT ON PHARMA STRATEGY
  • IDNs require a different pharma sales model
  • Pharma needs to employ a tailored and coordinated approach to meet the IDN challenges
  • Bibliography
List of Figures
Figure 1: Estimate of the global population, by age, 1950-2050
Figure 2: Proportion of the drug budget taken up by new medicines in the US and Europe, 2006-21
Figure 3: Publicly announced physician group mergers and acquisitions, 2011-15
Figure 4: Top 25 IDNs ranked by total number of facilities
Figure 5: Total number of doctors (doctors of medicine and doctors of osteopathic medicine), by facility
Figure 6: Total number of medical offices and groups, by facility
Figure 7: Total number of nursing homes, by facility
Figure 8: Community Health Systems net operating revenues, 2011-16
Figure 9: Kaiser Permanente health plan membership, by region
Figure 10: Kaiser Permanente healthcare professionals and other staff (approximate figures)
Figure 11: Kaiser Permanente annual operating revenue, 2008-17 (projected)
Figure 12: Geisinger Health Plan membership
Figure 13: Number of visits and admissions in 2015 for the Geisinger Health System
Figure 14: Patients cared for each day at Providence Health & Services (2016)
Figure 15: Integrated care’s potential impact on management of disease according to physicians’ opinions (by therapeutic area)
Figure 16: Increases in volumes of patients are more likely in hospital-owned or affiliated practices than in independent practices, Q1 2015-Q1 2016
Figure 17: Oncology practice affiliations, 2015-16
Figure 18: Reasons that oncology practices affiliate, 2015-16
Figure 19: Oncologists’ satisfaction scores with IDNs, 2014-16
Figure 20: Most frequently used real-world data sources, by organization type
Figure 21: Physicians’ belief that pharma and medtech can play a role in integrated care
Figure 22: Major areas addressed in service provision by the pharmaceutical industry

List of Tables
Table 1: Integrated care: benefits to patients and society
Table 2: Integrated care: focusing on similarities and differences
Table 3: Mayo Clinic coverage statistics
Table 4: A 2016 overview of the numbers and services at Providence Health & Services
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll